These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11429395

  • 1. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function.
    Hoffstedt J, Iliadou A, Pedersen NL, Schalling M, Arner P.
    Br J Pharmacol; 2001 Jul; 133(5):708-12. PubMed ID: 11429395
    [Abstract] [Full Text] [Related]

  • 2. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.
    Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P.
    J Clin Invest; 1997 Dec 15; 100(12):3005-13. PubMed ID: 9399946
    [Abstract] [Full Text] [Related]

  • 3. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
    Lönnqvist F, Wahrenberg H, Hellström L, Reynisdottir S, Arner P.
    J Clin Invest; 1992 Dec 15; 90(6):2175-86. PubMed ID: 1334970
    [Abstract] [Full Text] [Related]

  • 4. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells.
    Rydén M, Faulds G, Hoffstedt J, Wennlund A, Arner P.
    Diabetes; 2002 May 15; 51(5):1601-8. PubMed ID: 11978662
    [Abstract] [Full Text] [Related]

  • 5. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue.
    Arner P, Kriegholm E, Engfeldt P.
    J Pharmacol Exp Ther; 1991 Oct 15; 259(1):317-22. PubMed ID: 1681086
    [Abstract] [Full Text] [Related]

  • 6. Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation.
    Jocken JW, Blaak EE, Schiffelers S, Arner P, van Baak MA, Saris WH.
    Int J Obes (Lond); 2007 May 15; 31(5):813-9. PubMed ID: 17130852
    [Abstract] [Full Text] [Related]

  • 7. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
    Bruck H, Leineweber K, Park J, Weber M, Heusch G, Philipp T, Brodde OE.
    Clin Pharmacol Ther; 2005 Sep 15; 78(3):232-8. PubMed ID: 16153394
    [Abstract] [Full Text] [Related]

  • 8. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis.
    Rydén M, Hoffstedt J, Eriksson P, Bringman S, Arner P.
    Int J Obes Relat Metab Disord; 2001 Nov 15; 25(11):1599-603. PubMed ID: 11753577
    [Abstract] [Full Text] [Related]

  • 9. Blunted beta-adrenoceptor-mediated fat oxidation in overweight subjects: a role for the hormone-sensitive lipase gene.
    Jocken JW, Blaak EE, van der Kallen CJ, van Baak MA, Saris WH.
    Metabolism; 2008 Mar 15; 57(3):326-32. PubMed ID: 18249203
    [Abstract] [Full Text] [Related]

  • 10. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S, Shimizu M, Lönnqvist F, Nordenström J, Arner P.
    J Clin Invest; 1995 May 15; 95(5):2239-45. PubMed ID: 7738189
    [Abstract] [Full Text] [Related]

  • 11. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
    Reynisdottir S, Ellerfeldt K, Wahrenberg H, Lithell H, Arner P.
    J Clin Invest; 1994 Jun 15; 93(6):2590-9. PubMed ID: 8200997
    [Abstract] [Full Text] [Related]

  • 12. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
    Hellström L, Wahrenberg H, Reynisdottir S, Arner P.
    J Clin Endocrinol Metab; 1997 Jan 15; 82(1):159-66. PubMed ID: 8989252
    [Abstract] [Full Text] [Related]

  • 13. Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis.
    Lima JJ, Mauras N, Kissoon N, Wang J, Wiltrout SA, Sylvester JE.
    Metabolism; 2005 Apr 15; 54(4):492-9. PubMed ID: 15798957
    [Abstract] [Full Text] [Related]

  • 14. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
    Van Harmelen V, Lönnqvist F, Thörne A, Wennlund A, Large V, Reynisdottir S, Arner P.
    Int J Obes Relat Metab Disord; 1997 Nov 15; 21(11):972-9. PubMed ID: 9368819
    [Abstract] [Full Text] [Related]

  • 15. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
    Hellström L, Reynisdottir S, Langin D, Rössner S, Arner P.
    Int J Obes Relat Metab Disord; 1996 Aug 15; 20(8):745-52. PubMed ID: 8856398
    [Abstract] [Full Text] [Related]

  • 16. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
    Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M.
    Br J Pharmacol; 1996 Mar 15; 117(5):907-13. PubMed ID: 8851509
    [Abstract] [Full Text] [Related]

  • 17. Lipolytic effects of beta1, beta2 and beta3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues.
    Portillo MP, Rocandio AM, Garcia-Calonge MA, Diaz E, Campo E, Martinez-Blazquez C, Errasti J, del Barrio AS.
    Rev Esp Fisiol; 1995 Dec 15; 51(4):193-200. PubMed ID: 8907433
    [Abstract] [Full Text] [Related]

  • 18. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
    Hellström L, Rössner S, Hagström-Toft E, Reynisdottir S.
    Int J Obes Relat Metab Disord; 1997 Apr 15; 21(4):314-20. PubMed ID: 9130030
    [Abstract] [Full Text] [Related]

  • 19. Relationship between beta-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women.
    Eriksson P, Dahlman I, Rydén M, Hoffstedt J, Arner P.
    Int J Obes Relat Metab Disord; 2004 Feb 15; 28(2):185-90. PubMed ID: 14610528
    [Abstract] [Full Text] [Related]

  • 20. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
    Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P.
    J Clin Invest; 1995 Mar 15; 95(3):1109-16. PubMed ID: 7883959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.